This analysis reveals RAR as a valuable biomarker for detecting COVID-19 pneumonia, indicating the need for clinical attention in high-risk groups.
RAR represents a promising biomarker for the early detection and risk stratification of COVID-19 pneumonia. By simultaneously capturing hematologic and metabolic disturbances, RAR provides a more comprehensive reflection of disease severity. The observed age-mediation effect suggests that elderly individuals with elevated RAR may face heightened risk, warranting enhanced clinical monitoring or prioritized intervention.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: